📢 Cancers MDPI was awarded an updated Impact Factor of 4.5 in the 2023 Journal Citation Reports released by Clarivate in June 2024. The journal rank has now been upgraded to JCR Q1 (78/322 in the 'Oncology' category, 5-Year Impact Factor: 4.9). 👉 Read more: https://lnkd.in/g7JUNySw
Cancers MDPI
Verlagswesen für Bücher und Zeitschriften
Cancers Editorial Office (IF: 5.2, ISSN 2072-6694) International, Open Access Journal, Covering All Aspects of Oncology
Info
Cancers (ISSN 2072-6694; CODEN: CANCCT) is an international, peer-reviewed open access journal on oncology. It publishes article types including Research Papers, Reviews, Editorials, Communications, etc. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Cancers features (1) Original Articles reporting on novel and original findings; (2) Clinical Observations accompanied by analysis and discussion; (3) Communications reporting small scale studies that include important new information; (4) timely Reviews and Topical Issues on cutting edge fields in oncology. In addition, we accept well-designed studies showing meaningful but negative results. By doing this, we encourage scientists to share those data so that they would not need to repeat the experiments that somebody else has already done. The scope of Cancers includes (but is not limited to): Cancer pathophysiology Cancer causes Cancer diagnosis Cancer screening Cancer prognosis Cancer prevention, initiation, progression, and treatment
- Website
-
https://www.mdpi.com/journal/cancers
Externer Link zu Cancers MDPI
- Branche
- Verlagswesen für Bücher und Zeitschriften
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Basel
- Art
- Privatunternehmen
Orte
-
Primär
St. Alban-Anlage 66
Basel, CH
Beschäftigte von Cancers MDPI
-
Ravindra Kumar
Senior Scientist|Computational Biologist|Bioinformatician|Data Analyst|Epigenetics|Machine Learning|Deep Learning|Algorithm Developer|Bioinformatics…
-
Natália Roque, MSc, PhD
Medical Science Liaison | MSL Rare Disease at Sanofi |
-
Alok Kumar
Ph.D.[Medicine, Kyoto University]; PI: Prof. Tasuku Honjo [Nobel Prize, Medicine, 2018]
-
Meysam Sarshar
Postdoctoral Research Fellow
Updates
-
🚨New Special Issue “New Statistical and Machine Learning Methods for Cancer Research: Technologies for Adaptive Trials, Precision Therapies and Drug Development” edited by Dr. Anjishnu Banerjee (Medical College of Wisconsin) is open for submissions!👏 🗓Deadline for manuscript submissions: 25 February 2025. 💬Find more details here: https://lnkd.in/dpSBAueB
-
-
📢Today we share the #Review "Endoscopic Ultrasound Guided Biliary Drainage in Malignant Distal Biliary Obstruction" 👏by Danilo Paduano et al. Humanitas University 📌Link here: https://lnkd.in/dT-AR7Ka Keywords: MBO; EUS; LAMS
-
-
💬Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths worldwide. Today, we share the highly cited papers on this topic✅ 📌Read more publications for free in Cancers about CRC at: https://lnkd.in/dsJUsVKt
-
-
Cancers MDPI hat dies direkt geteilt
Another excellent article, this time published in Cancers MDPI on the role of opioids in pain control and their pro- and anti-tumor action. Congratulations to everyone, especially to Ana Vidal Pinheiro AMANDIO DOURADO; Isabel Pires Onevet Group;UNAVETS
-
🔊Today we share the #Article "Merkel Cell Polyomavirus: Infection, Genome, Transcripts and Its Role in Development of Merkel Cell Carcinoma" 👨🔬by Roland Houben et al. Universitätsklinikum Würzburg 🔗Link here: https://lnkd.in/dEMaShcM Keywords: Merkel cell carcinoma; polyomavirus; T antigen
-
-
💬We share the Special Issue "Insights from the Editorial Board Member" edited by Dr. Carlos Moreno (Emory University)!👏 ⏰Deadline for manuscript submissions: 31 December 2025. Find more details here▶ https://lnkd.in/dV9VsTEw
-
-
💬Happy to share the Special Issue "Innovations in Addressing Disparities in Cancer" edited by Prof. Dr. Rajesh Singh and Prof. Dr. Shailesh Singh, Morehouse School of Medicine❕ 🗓Deadline for manuscript submissions: 31 December 2025. 📌Find more details here▶ https://lnkd.in/dFP5QniM
-
-
🎖️Check out the Editor's Choice #Article "Improved Accuracy and Sensitivity in Diagnosis and Staging of Lung Cancer with Systematic and Combined Endobronchial and Endoscopic Ultrasound (EBUS-EUS): Experience from a Tertiary Center" ✍by Abdenor Badaoui et al. Université catholique de Louvain 🔗Link here: https://lnkd.in/drjWVeMS 🔸Accurate diagnosis of lymph node metastasis of solid cancer is important when predicting the prognosis and determining surgical indication. The authors demonstrated superiority of combined endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and endoscopic ultrasound-guided tissue acquisition (EUS-TA) in patients with lung cancer, which would be a standard technique in determination of staging of lung cancer.🔸
-
-
📢Today we share the #Article "Validation of MRI-Based Models to Predict MGMT Promoter Methylation in Gliomas: BraTS 2021 Radiogenomics Challenge" 👏by Kyu Sung Choi et al. Seoul National University Hospital 📌Access the full paper here: https://lnkd.in/dJi5v6Kt
-